TrialFrontiers in immunology2023

Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1-positive advanced cervical cancer: a phase II, single-arm study.

Jusheng An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.